Plenary Session - inactive due to federal service
By Vinay Prasad, MD MPH
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Vinay Prasad, MD MPH
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 190
Reviews: 2
Episodes: 397
Disappointed MD PhD
Feb 20, 2025
Used to enjoy the cancer data reviews, but COVID radicalized Vinay's view of the world. His recent bloviations against the CDC, NIH, and other agencies parrot a Joe Rogan podcast, rather than a data driven academic chat. Very disappointing.
Apr 10, 2022
Description
Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.
A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
| Episode | Date |
|---|---|
|
CABINET - trial - Cabozantinib for NET
|
Feb 20, 2025 |
|
Trump is breaking media brains / NIH cuts indirect payments and scientists freak out
|
Feb 19, 2025 |
|
RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom
|
Feb 19, 2025 |
|
Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints
|
Feb 19, 2025 |
|
Why the NIH is a broken funding system
|
Feb 19, 2025 |
|
CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!
|
Feb 19, 2025 |
|
Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!
|
Feb 01, 2025 |
|
The ENTIRE healthcare system is broken, not just health insurance companies
|
Jan 27, 2025 |
|
Alcohol - Is it healthy? Everything you need to know about Beer, Wine and Spirits
|
Jan 24, 2025 |
|
2 HOUR ASH Presentation with AARON GOODMAN & MANNI & More
|
Dec 11, 2024 |
|
Systematic Reviews - An Introduction⧸ How to do them⧸ Search Strategies⧸ Common Errors
|
Nov 13, 2024 |
|
Special post-ESMO 2024 edition !
|
Nov 03, 2024 |
|
Artificial Intelligence in Medicine - My Keynote
|
Oct 28, 2024 |
|
Masking Mistakes - my panel discussion at the Emory Center for Ethics
|
Oct 16, 2024 |
|
How We Can Do Better As A County Hospital
|
Aug 31, 2024 |
|
Driver mutation lung cancer - My lecture
|
Aug 02, 2024 |
|
Post ASCO wrap up with Timothee Olivier
|
Jun 23, 2024 |
|
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version
|
Jun 05, 2024 |
|
Asco Prequel - We talk about what to look for
|
May 30, 2024 |
|
A SM crossover - Cifu, Prasad, Mandrola
|
May 27, 2024 |
|
When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai
|
May 17, 2024 |
|
Cifu, Mandrola, Prasad - SM crossover
|
May 10, 2024 |
|
Patient advocates funded by Pharma
|
Apr 17, 2024 |
|
FDA makes MRD the basis for AA
|
Apr 12, 2024 |
|
Beta Blockers After Heart Attacks Don't Work
|
Apr 09, 2024 |
|
Blood based and Stool DNA colon cancer screening - Two NEJM papers
|
Mar 27, 2024 |
|
Keynote 564 - a flawed study
|
Feb 01, 2024 |
|
CONTACT-01 Cabo/ Atezo in Prostate Cancer - An Unethical trial
|
Jan 27, 2024 |
|
CAR T causes MDS??? Manni, Goodman, Raj, Prasad
|
Dec 28, 2023 |
|
Timothee and Prasad talk 2023 cancer trials
|
Dec 24, 2023 |
|
Aaron Goodman Prasad ASH UPDATES
|
Dec 20, 2023 |
|
Mandrola and Prasad
|
Dec 17, 2023 |
|
COVID19 Policy: What the US Got Wrong
|
Nov 26, 2023 |
|
Lecture 1 of 4 Curacao - How to Keep Up with Literature
|
Nov 24, 2023 |
|
Advice Pre-Med Students | Lecture at UC Berkeley
|
Nov 11, 2023 |
|
Radiation oncology in GI malignancy - Nina Sanford and Bill Hall
|
Oct 31, 2023 |
|
Hawai Keynote - Coffee and colon cancer & Censoring & More
|
Oct 23, 2023 |
|
Ethics: How IRBs Can Do Better | My Denmark Lectures (Sept 2023) 3 Of 3
|
Oct 19, 2023 |
|
Prasad's lecture gets cancelled/ Cifu Gets COVID a SM crossover
|
Oct 16, 2023 |
|
The State Of Immunotherapy In Oncology | My Denmark Lectures (Sept 2023) 2 Of 3
|
Oct 09, 2023 |
|
Do We Have Good Evidence For New Drugs? My Denmark Lectures (Sept 2023) 1 Of 3
|
Oct 04, 2023 |
|
Great And Crazy Things We Do In Medicine
|
Sep 20, 2023 |
|
Fixing Cancer Medicine w/ Timothee Olivier
|
Sep 12, 2023 |
|
Coumadin, ECMO, RCTs and more
|
Sep 11, 2023 |
|
Prasad and Mandrola discuss recent journal articles/ Republicans/ Stenting
|
Aug 23, 2023 |
|
Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover
|
Jul 10, 2023 |
|
Testosterone/ Should Scientists Debate/ Mike Joyner
|
Jun 28, 2023 |
|
Post Protocol Therapy - QOL - Adjuvant - Olivier Joins VP
|
Jun 10, 2023 |
|
ADAURA OS RESULTS - THE TRIAL WAS UNETHICAL
|
Jun 08, 2023 |
|
OBS studies vs RCTs - Trial Emulation - RCT Duplicate - We debate recent JAMA Paper
|
May 17, 2023 |
|
Myeloma Roundtable - Manni M. Raj C. VP discuss controversies
|
May 13, 2023 |
|
Mammographic Screening : A complete review of the evidence
|
May 11, 2023 |
|
The Crushing, Cruel Cost of Cancer Drugs - My Lecture
|
Apr 29, 2023 |
|
Sensible Med Crossover - Cifu/ Mandrola/ Prasad & Wallensky
|
Apr 24, 2023 |
|
Cochrane Mask Debates - Jefferson/ Heneghan/ Prasad
|
Apr 15, 2023 |
|
Zeb Jamrozik - Vaccine errors/ Sweden/ Equipoise & Science itself
|
Apr 12, 2023 |
|
Harvard-MIT Center for Reg. Science Lecture (4-4-23) - Dubious FDA drug Approvals
|
Apr 05, 2023 |
|
5.47 - Real World Evidence - Keynote Lecture in Denmark
|
Mar 26, 2023 |
|
5.46 - What is Science: reflections on the field
|
Mar 10, 2023 |
|
5.45 - Bar Karmma - Karmma 3 | Idacel vs 'standard care
|
Mar 07, 2023 |
|
More basics on randomized controlled trials - Part 2
|
Mar 02, 2023 |
|
RCT 101 And Papa Heme
|
Feb 28, 2023 |
|
Tom Newman And VP Discuss Public Health
|
Feb 22, 2023 |
|
5.41 - Michael Putman MCW debates me on recent policy Qs
|
Feb 16, 2023 |
|
Sensible Med Superbowl Plenary Session Crossover
|
Feb 13, 2023 |
|
5.39 - Sotorasib and Codebreak 200
|
Feb 10, 2023 |
|
Myeloma Twitter Just Makes Things Up - Lessons for All Oncologists & Expertise
|
Jan 22, 2023 |
|
5.37 - Keynote Lecture on Physician Burnout
|
Jan 15, 2023 |
|
5.36 - ASH UPDATE #4 - GEM CESAR
|
Dec 30, 2022 |
|
5.35 - ASH Update #3 - the Ascent Trial
|
Dec 29, 2022 |
|
5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed
|
Dec 24, 2022 |
|
5.33 USC Grand Rounds Hematology
|
Dec 23, 2022 |
|
5.32 - ASH Update #1 - Talquetamab NEJM
|
Dec 11, 2022 |
|
5.31 - MUST LISTEN Grand Rounds - COVID19 Updates
|
Dec 08, 2022 |
|
5.30 Rajkumar vs Goodman; Long COVID vs Long URI
|
Dec 03, 2022 |
|
5.29 Smart Start is a useless Lymphoma study
|
Nov 27, 2022 |
|
5.28 - Pandemic Amnesty or Accountability with Paul Fenyves
|
Nov 12, 2022 |
|
5.27 - Multiple Myeloma - Do Our Trials Help Patients?
|
Nov 08, 2022 |
|
5.26 - Hawaii Oncology Association Keynote Lecture
|
Nov 06, 2022 |
|
5.25 - Neurosurgery Grand Rounds by Vinay Prasad
|
Nov 03, 2022 |
|
5.24 Vlad Kogan is back to discuss Kids Test Scores
|
Nov 01, 2022 |
|
5.24 - Gerald Hsu MD PhD UCSF Heme Onc Program Director
|
Oct 28, 2022 |
|
5.23 - Subclinical Myocarditis
|
Oct 19, 2022 |
|
5.23 - ID Ethicist joins me for a 6th discussion of COVID19 policy
|
Oct 18, 2022 |
|
5.22 NordICC trial interview with PI Michael Bretthauer - Offer but don't Nudge
|
Oct 15, 2022 |
|
5.21 Science Mag Editor Condemns Ladapo But Silent About Jha
|
Oct 14, 2022 |
|
5.20 The Great Colonoscopy Debate
|
Oct 11, 2022 |
|
5.19 - NEJM's first ever RCT of Colonoscopy-- Explained
|
Oct 09, 2022 |
|
5.18 Lecture to Heme Onc Fellows - POLO; Javelin 100 bladder
|
Oct 08, 2022 |
|
5.17 - The State Of Precision Oncology
|
Oct 07, 2022 |
|
5.16 - Aaron Goodman UCSD
|
Sep 29, 2022 |
|
5.15 - How To Apply For And Get Your Perfect First Job
|
Sep 21, 2022 |
|
Unspoken Rules of Oncology - Malignant BC Part 6
|
Sep 18, 2022 |
|
Malignant Book Club - Episode 7 - famous trials
|
Sep 09, 2022 |
|
5.12 - Academics Vs Industry - A.Goodman S.Loghavi D.Steensma V.P.
|
Sep 03, 2022 |
|
5.11 - Malignant Book Club - Part 5
|
Aug 26, 2022 |
|
5.10 - Adam Cifu on clinical excellence
|
Aug 24, 2022 |
|
5.09 - Malignant Book Club Part 4
|
Aug 22, 2022 |
|
5.08 - LaceWing RCT Phase 3 Blood - Spin Cycle
|
Aug 18, 2022 |
|
5.07 - Plenary Session Alps Edition
|
Aug 10, 2022 |
|
5.06 - POLO trial now has OS results - OMG
|
Jul 21, 2022 |
|
5.05 - Citations, Metrics, Rankings in Oncology & Medicine
|
Jul 18, 2022 |
|
5.04 - Echelon 1 reports OS benefit - But does it add up?
|
Jul 14, 2022 |
|
5.03 - VPs Grand Rounds Lecture - Evidence Based Medicine - Will it Survive?
|
Jul 13, 2022 |
|
5.02 - Listener Questions - Cancer & Evidence Philosophy - What this Pod Offers
|
Jul 11, 2022 |
|
5.01 - How To Read Randomized Trials In Cancer
|
Jul 07, 2022 |
|
Lies and Exaggerations about Kids Vaccines < 5 years Old is Bad Public Health
|
Jun 22, 2022 |
|
Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer
|
Jun 20, 2022 |
|
Kids Vaccine For Under 5 years Old
|
Jun 18, 2022 |
|
H. Jack West; Lung Cancer; Podcasting; TeleHealth: PACIFIC; ADAURA;CM816: KN189
|
Jun 18, 2022 |
|
QuANTUM - Quizartinib Front Line - Ethics of Global Trials
|
Jun 15, 2022 |
|
4.67 Teclistimab for R/R Multiple Myeloma
|
Jun 09, 2022 |
|
4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??
|
Jun 08, 2022 |
|
4.65 DESTINY BREAST 04 - A complex trial to deconstruct
|
Jun 07, 2022 |
|
4.64 - DETERMINATION - Should we still use transplant Myeloma?
|
Jun 06, 2022 |
|
4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer
|
Jun 05, 2022 |
|
4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial
|
Jun 04, 2022 |
|
4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis
|
May 27, 2022 |
|
4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods
|
May 21, 2022 |
|
4.59 - How to be a better reader of case control studies
|
May 17, 2022 |
|
4.58 - Myeloma is a broken field - New BLOOD Paper!
|
May 14, 2022 |
|
4.57 - COVID19 and the Failures of Public Health w/ Leslie Bienen
|
May 06, 2022 |
|
4.56 - Fifth Installment of the brilliant Zeb Jamrozik
|
May 04, 2022 |
|
4.55 - Compilation Of Recent Covid Monologues
|
May 01, 2022 |
|
4.54 - Eric Collisson Professor, GI Oncologist, Physician Scientist
|
Apr 30, 2022 |
|
4.53 John Ioannidis lectures the VKPrasad Lab about COVID19
|
Apr 27, 2022 |
|
4.52 Vinay Prasad Gives a Lecture on COVID19 to a General Audience
|
Apr 24, 2022 |
|
4.51 - Vinay Prasad is Interviewed by Kristina Jenei About Academic Medicine
|
Apr 22, 2022 |
|
4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club
|
Apr 21, 2022 |
|
4.49 - Malignant Book Club Part 3 Audio
|
Apr 15, 2022 |
|
4.48 - The Truth About RCTs In Cancer Medicine
|
Apr 07, 2022 |
|
4.47 Malignant Book Club w/ Dr. Olivier Part 2 of 9
|
Mar 22, 2022 |
|
4.46 - Cancer Monologue and Lecture #5 from VP's Class on How to Appraise Medical Literature
|
Mar 16, 2022 |
|
4.45 - Malignant Book Club w/ Dr. Olivier Part 1 of 9
|
Mar 12, 2022 |
|
4.44 - Cost Of Cancer Drugs - Basics In Cancer Drug Policy
|
Mar 04, 2022 |
|
4.43 - VKPrasad Lab Update Part 2 With Timothee Olivier
|
Mar 01, 2022 |
|
4.42 - Timothee Olivier, Geneva in the first Installment of VKPrasad Lab updates
|
Feb 24, 2022 |
|
4.41 The Mask Debacle with Jacob Hale Russell
|
Feb 19, 2022 |
|
4.40 H Gilbert Welch - Melanoma Screening; Blood Based Cancer testing; Lung CA screening
|
Jan 28, 2022 |
|
4.39 Dr Zeb Jamrozik, ID ethicist, practicing doctor, great thinker
|
Jan 27, 2022 |
|
4.38 COVID-19: Boosters for Adults and Teens, Paul Offitt, Testing, Myocarditis, Campus Restrictions
|
Jan 21, 2022 |
|
4.37 MEMOIR & The Emperor Has No Clothes (a Critique of Cancer Care) with Dr. Christopher Booth
|
Jan 06, 2022 |
|
4.36 Where Are We Now with COVID-19? with Dr. John Ioannidis
|
Jan 04, 2022 |
|
4.35 Omicron, Travel Bans, Masks, Vaccine Mandates with Dr. Zeb Jamrozik
|
Dec 31, 2021 |
|
4.34 ASH Lymphoma Updates: POLARIX, ZUMA 7, BELINDA w/ Papa Heme and DRG
|
Dec 24, 2021 |
|
4.33 Melanoma: Tebentafusp, Stage Migration, Adjuvant Therapy, Training with Dr. Adil Daud
|
Dec 22, 2021 |
|
4.32 Oral Azacitidine for AML and Nelarabine for T-ALL with Dr. Bernard Marini
|
Dec 03, 2021 |
|
4.31 Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma with Dr. William Hall
|
Nov 24, 2021 |
|
4.30 COVID in Children and the US FDA Vaccine Advisory Committee with Dr. Cody Meissner
|
Nov 22, 2021 |
|
4.29 Scientific and Ethical Failures of COVID-19 with Dr. Zeb Jamrozik
|
Nov 11, 2021 |
|
4.28 Calling Out Unethical Clinical Trials, Melflufen, and Academic Oncology with Dr. Aaron Goodman
|
Nov 06, 2021 |
|
4.27 Economics and Medicine with the Host of Freakonomics, M.D., Dr. Anupam Bapu Jena
|
Oct 29, 2021 |
|
4.26 Recent Kidney Cancer Trials, Unethical Cancer Clinical Trial, & CASSIOPEIA
|
Oct 28, 2021 |
|
4.25 A Critique of COVID-19 Health Policy with Infectious Disease Ethicist Dr. Zeb Jamrozik
|
Oct 20, 2021 |
|
4.24 COVID-19: Moderna booster, Myocarditis, Progressivism, Social Media, Masks, Tests, J&J booster
|
Oct 16, 2021 |
|
4.23 Access to Cancer Medicines, Standard of Care in Oncology, and the Oncology Value Paradigm
|
Oct 15, 2021 |
|
4.22 Honoring Dr. Elilhu Estey and His Decades-Long Oncology Career
|
Oct 12, 2021 |
|
4.21 Cognitive Errors in Medical Decision-Making with Dr. Daniel Morgan & COVID-19 Policy
|
Sep 22, 2021 |
|
4.20 Vaccinating Kids and College Students, Boosters, Outdoor Masking, Bangladesh RCT, & more!
|
Sep 14, 2021 |
|
4.19 Censoring: Not on Facebook, but in Kaplan-Meier Curves
|
Sep 08, 2021 |
|
4.18 Dementia Interventions, Skills for Epidemiologists, & Aducanumab with Dr. Maria Glymour
|
Sep 01, 2021 |
|
4.17 RCTs for Cancer Drug Approval with Dr. Saroj Niraula & Myeloma Studies with Dr. Manni Mohyuddin
|
Aug 27, 2021 |
|
4.16 Treating Lymphoma, Histiocytic Disorders, Learning by Teaching, & More! with Dr. Bita Fakhri
|
Aug 21, 2021 |
|
4.15 #AllCOVID-19: the Tough Questions About Policies Concerning the Delta Variant of COVID-19
|
Aug 19, 2021 |
|
4.14 Evolution of GI Cancer Therapy, Editing JCO, Advice for Clinical Trialists with Dr. Alan Venook
|
Aug 11, 2021 |
|
4.13 Lessons from Publishing 300 Peer-Reviewed Papers & What Telemedicine Will Do to Cancer Care
|
Aug 06, 2021 |
|
4.12 Real-World Survival Outcomes for Pertuzumab and T-DM1 with Dr. Josee-Lyne Ethier
|
Aug 03, 2021 |
|
4.11 CheckMate 274, PARADIGM-HF/Ernesto, POLO, & an AI Approach to Reducing Knee Pain
|
Jul 31, 2021 |
|
4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien
|
Jul 28, 2021 |
|
4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma
|
Jul 23, 2021 |
|
4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021
|
Jul 16, 2021 |
|
4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad
|
Jul 09, 2021 |
|
4.06 CAR-T, Oncology RCTs, Social Media, Myeloma, and Career Decisions with Dr. Rahul Banerjee
|
Jul 08, 2021 |
|
4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari
|
Jul 07, 2021 |
|
4.04 Treatment Algorithm for Follicular Lymphoma & Assessing RCTs
|
Jun 26, 2021 |
|
4.03 Multiple Myeloma, Productivity Metrics, and Field Changes in Oncology with Dr. Nina Shah
|
Jun 18, 2021 |
|
4.02 The History of Breast Cancer Research and Treatment with Dr. George Sledge
|
Jun 15, 2021 |
|
4.01 Highlights from the 2021 ASCO Annual Meeting
|
Jun 11, 2021 |
|
3.90 Redesigning Health Care, Overuse, Burnout, and COVID-19 Groupthink with Dr. Marty Makary
|
Jun 04, 2021 |
|
3.89 How to Think About COVID-19 Policy with Rare Events and Declining Probabilities
|
Jun 03, 2021 |
|
3.88 Behind the Scenes for the One-Year Anniversary of Malignant with Dr. Vinay Prasad
|
Jun 02, 2021 |
|
3.87 Round Table on Multiple Myeloma Initial Therapy, High Risk, and Maintenance
|
May 31, 2021 |
|
3.86 Lenvatinib plus Pembrolizumab or Everolimus for Advanced RCC with Dr. Karine Tawagi
|
May 28, 2021 |
|
3.85 Med-Psych, Palliative Care, and Respect for Autonomy and Dignity with Dr. Joshua Briscoe
|
May 27, 2021 |
|
3.84 DLBCL, Bad Cancer Drugs and Bad Twitter Users with Dr. Aaron Goodman
|
May 26, 2021 |
|
3.83 MetaResearch, Reproducibility, Expertise, & Early Career Researchers with Dr. Ioana Cristea
|
May 25, 2021 |
|
3.82 Classical Hematology Chat on CVT and VITT with Drs. Sven Olson and Joseph Shatzel
|
May 24, 2021 |
|
3.81 Impact of COVID-19 on Sociology, Politics, and Democracy with Genève Campbell
|
May 21, 2021 |
|
3.80 ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) with Drs. Bishal Gyawali and Nathan Cherny
|
May 20, 2021 |
|
3.79 Sweden's Stance on COVID-19, Hydroxychloroquine, Schools, & Mask Data with Dr. Cathrine Axfors
|
May 19, 2021 |
|
3.78 Astronomy, Being a Scientist, and the Culture of the Academy with Dr. Avi Loeb
|
May 18, 2021 |
|
3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe
|
May 17, 2021 |
|
3.76 COVID-19 Transmission in Schools with Dr. Christopher Whaley and Dr. Neeraj Sood
|
May 14, 2021 |
|
3.75 All Things COVID-19 with Infectious Disease Professor Dr. Paul Edward Sax
|
May 14, 2021 |
|
3.74 Artificial Intelligence in Dermatology with Dr. Roxana Daneshjou
|
May 13, 2021 |
|
3.73 CheckMate 577: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
|
May 12, 2021 |
|
3.72 Industry Payments to US Physicians for Cancer Therapeutics with Dr. Daniel Meyers
|
May 11, 2021 |
|
3.71 How Research Influences Policy with Dr. Kirsten Bibbins-Domingo
|
May 05, 2021 |
|
3.70 The Motivation We Need to Reach the End of the COVID-19 Pandemic with Dr. Monica Gandhi
|
Apr 30, 2021 |
|
3.69 Reporting of Postprotocol Therapies in Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin
|
Apr 29, 2021 |
|
3.68 A Career in Academic Medicine & Challenges of 2021 with Former Harvard Dean, Dr. Jeffrey Flier
|
Apr 29, 2021 |
|
3.67 Thoughts on PhD Programs and Idecabtagene Vicleucel with Dr. David Russler-Germain
|
Apr 23, 2021 |
|
3.66 COVID-19 Policies and Progressing Past Disagreement with Dr. Martin Kulldorff
|
Apr 16, 2021 |
|
3.65 Banning Books, Social Media, & Medical Education with Dr. Adam Cifu
|
Apr 14, 2021 |
|
3.64 A Legal and Philosophical View on COVID-19 with Samantha Godwin
|
Apr 12, 2021 |
|
3.63 The Medical Scientist Training Program with Dr. David Russler-Germain
|
Apr 08, 2021 |
|
3.62 COVID-19 Transmission, Vaccines, & Olaparib with Dr. Tom Beer
|
Apr 08, 2021 |
|
3.61 The Neuroscience and Psychology of Recreational Drug Use in Adults with Dr. Carl Hart
|
Apr 06, 2021 |
|
3.60 Drugs for Acute Lymphoblastic Leukemia with Dr. Bernard Marini
|
Mar 31, 2021 |
|
3.59 Genetic Alterations Linked to SARS-CoV-2 Acquisition and Bad Outcomes with Dr. Nathan Pearson
|
Mar 30, 2021 |
|
3.58 Expertise and Disinformation with Jacob Hale Russell
|
Mar 26, 2021 |
|
3.57 Career Paths and Evolution of the Oncology Randomized Clinical Trial with Dr. Christopher Booth
|
Mar 26, 2021 |
|
3.56 Quality of Control Groups in RCTs of Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin
|
Mar 25, 2021 |
|
3.55 Equity in Vaccine Distribution, Cancel Culture, and Zero COVID-19 with Dr. Matthew Smith
|
Mar 24, 2021 |
|
3.54 The Passing of Dr. José Baselga
|
Mar 23, 2021 |
|
3.53 Updates on COVID-19 and Looking Back Over the Last Year with Dr. Aaron Richterman
|
Mar 19, 2021 |
|
3.52 Medicine, Leadership, SARS-CoV-2, and Social Media with Dr. Bob Wachter
|
Mar 14, 2021 |
|
3.51 COVID-19 Modeling with Youyang Gu
|
Mar 12, 2021 |
|
3.50 Evildoer Marty Makary [SHORT]
|
Mar 11, 2021 |
|
3.49 The Role of Government in Public Health and in COVID-19 Policy with Dr. Robert Freudenthal
|
Mar 10, 2021 |
|
3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris
|
Mar 06, 2021 |
|
3.47 COVID-19 Vaccine Results, Messaging on a Patient Level, & Schools with Dr. Monica Gandhi
|
Mar 03, 2021 |
|
3.46 COVID-19 Risk, Cases, and Transmission in K-12 Schools with Dr. Tracy Høeg
|
Feb 27, 2021 |
|
3.45 USMLE Steps, Residency Match, & M.D. vs D.O. with Dr. Bryan Carmody
|
Feb 24, 2021 |
|
3.44 The Role of Philosophy, COVID-19 Policy, and COVID-19 Exceptionalism with Dr. Alex John London
|
Feb 17, 2021 |
|
3.43 Reviewing the Beat AML Master Trial
|
Feb 15, 2021 |
|
3.42 Overdiagnosis and Cutaneous Melanoma Diagnoses with Dr. Adewole Adamson and Dr. Benjamin Mazer
|
Feb 10, 2021 |
|
3.41 Building a Meta-Research Career and Constructing COVID-19 Health Policy with Dr. John Ioannidis
|
Feb 07, 2021 |
|
3.40 COVID-19 Vaccines, Origin of SARS-CoV-2, and Pandemic Mitigation with Prof Francois Balloux
|
Feb 05, 2021 |
|
3.39 Public Health Messaging on COVID-19 with Drs. Julia Marcus and Stefan Baral
|
Feb 04, 2021 |
|
3.38 Oncology During COVID-19 & RCTs from Low- vs High-Income Countries with Dr. Christopher Booth
|
Jan 29, 2021 |
|
3.37 Skepticism, COVID-19, and Debating Science in the Era of Trade-Offs with Jacob Hale Russell
|
Jan 27, 2021 |
|
3.36 Sustainable Ex-Vivo Seafood with Dr. Arye Elfenbein
|
Jan 22, 2021 |
|
3.35 The Secrets of Vermont in Taming the COVID-19 Pandemic with Anne Sosin
|
Jan 20, 2021 |
|
3.34 COVID-19 From a Philosopher's Point of View with Dr. Matthew Smith
|
Jan 15, 2021 |
|
3.33 Hematologic Malignancies and Transplantation with Dr. Aaron Goodman
|
Jan 12, 2021 |
|
3.32 Publishing Original Thought in Medical Journals with Dr. Stephen Bradley
|
Jan 08, 2021 |
|
3.31 Random Thoughts on Visiting Hospital Patients During COVID-19 and Norman Wang's Lawsuit
|
Jan 06, 2021 |
|
3.30 Benefit and Risk of SpaceOAR with Dr. William Hall
|
Jan 05, 2021 |
|
3.29 Censorship in Medicine with Jonathan Darrow
|
Dec 31, 2020 |
|
3.28 Exploring the History of Medicine with Dr. Adam Rodman, host of Bedside Rounds
|
Dec 21, 2020 |
|
3.27 All Recent Acute Myeloid Leukemia Drugs with Dr. Bernard Marini
|
Dec 16, 2020 |
|
3.26 The Importance of Debate and Dialogue with Dr. Saurabh Jha
|
Dec 15, 2020 |
|
3.25 Public Health Policy on the Risk of COVID-19 in Children with Dr. Alasdair Munro
|
Dec 12, 2020 |
|
3.24 KEYNOTE-177 & Mathematic Models for Fighting COVID-19 with Dr. Wesley Pegden
|
Dec 04, 2020 |
|
3.23 Capturing Your Audience with Dr. Zubin "ZDoggMD" Damania & JAVELIN 100 with Dr. Karine Tawagi
|
Nov 26, 2020 |
|
3.22 New Podcast, Opening Schools with Dr. Vladimir Kogan, Virtual Learning with Dr. Carycruz Bueno
|
Nov 21, 2020 |
|
3.21 Affirmative Action with Leah Litman, Cost Implications with Dr. DeMartino, & Dr. John Mandrola
|
Nov 13, 2020 |
|
3.20 Public Health Messaging, COVID-19 in the U.S. Northeast, Journal Club with a Fellow
|
Nov 07, 2020 |
|
3.19 COVID-19 and the AIDS Pandemics with Dr. Monica Gandhi & Classical Hematology Chat
|
Oct 30, 2020 |
|
3.18 Social Media and News with Dr. Benjamin Mazer & Caplacizumab for TTP with Dr. Tem Bendapudi
|
Oct 23, 2020 |
|
3.17 COVID-19 and Schools in Norway with Dr. Atle Fretheim & Cancer Biology with Dr. Anthony Letai
|
Oct 16, 2020 |
|
3.16 Non-Drug Interventions with Dr. Margaret McCartney & Cancer Biology with Dr. Jason Sheltzer
|
Oct 09, 2020 |
|
3.15 COVID-19 in Children with Dr. Alasdair Munro & Pandemic Public Health with Dr. Stefan Baral
|
Oct 06, 2020 |
|
3.14 COVID-19 with Dr. John Ioannidis & Trial Eligibility with Dr. Mary-Elizabeth Percival
|
Oct 03, 2020 |
|
3.13 COVID-19 and Schools, COVID-19 and Scott Atlas, and COVID-19 Policy
|
Sep 25, 2020 |
|
3.12 TMPRSS2, Cancer Imaging with Drs. Becker and Woo, Clinical Epidemiology with Dr. Thomas Newman
|
Sep 19, 2020 |
|
3.11 Experts, Lockdown, Affirmative Action, & COVID-19 and Hearts with Professor Darrel Francis
|
Sep 12, 2020 |
|
3.10 Colon Cancer Screening, Vascepa Patent with Jonathan Darrow, PREVENTT with Dr. Toby Richards
|
Sep 05, 2020 |
|
3.09 COVID-19 Risk, Financial Toxicity, & HALT-IT for Journal Club with Fellow Dr. Justine Ryu
|
Aug 29, 2020 |
|
3.08 Racial Concordance in Birthing Mortality & HERO for Journal Club with Fellow Dr. Michael Burns
|
Aug 22, 2020 |
|
3.07 Lung Cancer Omics and Mortality, PPIs and COVID-19, & RECIST with Dr. Elizabeth Eisenhauer
|
Aug 15, 2020 |
|
3.06 COVID-19 Vaccine Access, ADAURA, QOTW, & Journal Club with Fellow Dr. Karine Tawagi
|
Aug 07, 2020 |
|
3.05 LIVE! A Midsummer Night's Stream
|
Jul 30, 2020 |
|
3.04 Listener Questions & MedTwitter and Risk-Benefit Profile of Ramucirumab with Dr. Bishal Gyawali
|
Jul 24, 2020 |
|
3.03 The National Lung Matrix Trial & the Major Flaw of the SPRINT Trial with Dr. Mark Friedberg
|
Jul 18, 2020 |
|
3.02 BONUS! National Clinician Scholars Program with Dr. Hilary Seligman
|
Jul 13, 2020 |
|
3.01 Risk of COVID-19 Among Users of PPIs, Time to Treatment Initiation, & Dr. Lynora Saxinger
|
Jul 11, 2020 |
|
2.60 BONUS! Cancer Meta-Research 101: The Lay of the Land of Cancer Research
|
Jul 07, 2020 |
|
2.59 The Best Doctor, Selinexor, & Annotation Services for NGS with Drs. Katsoulakis and Kelley
|
Jul 03, 2020 |
|
2.58 RECOVERY & Twitter, Academic Debate, and Transitioning Your Career with Dr. Andrae Vandross
|
Jun 27, 2020 |
|
2.57 RECOVERY, Clinical Trials in the US, EFS, Writing, Dr. Raj Chetty, & Dr. Ian Tannock
|
Jun 19, 2020 |
|
2.56 HER2CLIMB & Misinformation and Disinformation with Dr. Cailin O'Connor
|
Jun 12, 2020 |
|
2.55 Hydroxychloroquine for COVID-19, ASCO, QOTW, Private Equity in Medicine with Dr. Jane Zhu
|
Jun 05, 2020 |
|
2.54 Classical Hematology Chat on Thrombosis in COVID-19 & Drugs for COVID-19 with Dr. Walid Gellad
|
May 31, 2020 |
|
2.53 Why Agreeing 65% with Someone is Important & COVID-19 Health Policy with Dr. Daniel Morgan
|
May 23, 2020 |
|
2.52 Malignant Audiobook, PROfound trial, & Literature and Medicine with Dr. Adam Cifu
|
May 16, 2020 |
|
2.51 BONUS! Clinical Trials Part 3
|
May 13, 2020 |
|
2.50 Neil Ferguson, Ending Lockdown, & Updates on COVID-19 Management with Dr. Benjamin Singer
|
May 07, 2020 |
|
2.49 COVID-19 Contrarians, Remdesivir, & Book Club on "Malignant" with OHSU HemOnc Fellows
|
May 02, 2020 |
|
2.48 BONUS! Introduction to Malignant: How Bad Policy and Bad Evidence Harm People with Cancer
|
Apr 25, 2020 |
|
2.47 Remdesivir, Cloth Masks, & Incentives for COVID-19 Drug Development with Dr. Ameet Sarpatwari
|
Apr 16, 2020 |
|
2.46 Psychology Unearthed by COVID-19 Precautions & Polygenic Risk Score with Dr. Venk Murthy
|
Apr 11, 2020 |
|
2.45 Viral Spread of SARS-CoV-2, Rationing Resources, "Evidence Fiasco", & Classical Hematology Chat
|
Apr 01, 2020 |
|
2.44 ICU Management of COVID-19 with Dr. Benjamin Singer
|
Mar 25, 2020 |
|
2.43 BONUS! Novel Coronavirus and the COVID-19 Response in Oregon with Dr. John Townes
|
Mar 18, 2020 |
|
2.42 Quality-of-Life Measurement in Oncology, KnowYourTumor, & Question of the Week
|
Mar 17, 2020 |
|
2.41 BONUS! Clinical Trials Part 2: Crossover and Control Arms
|
Mar 11, 2020 |
|
2.40 BEACON part 2, NALA, & Molecular Pathology and Next-Generation Sequencing with Dr. David Carr
|
Mar 05, 2020 |
|
2.39 Effectiveness of Newer-Generation Antidepressants with Dr. Michael Hengartner
|
Feb 27, 2020 |
|
2.38 KEYNOTE-048, Academic Currency, & Trials in Low/Mid-Income Countries with Dr. Bishal Gyawali
|
Feb 19, 2020 |
|
2.37 Careerism, Presenting Abstracts, Twitter and the K-Index, & Classical Hematology Chat
|
Feb 14, 2020 |
|
2.36 Thought Leaders, NELSON, & Reliance on P Values in Cancer Trials with Dr. Sam Rubinstein
|
Feb 07, 2020 |
|
2.35 BONUS! How to Keep Up with the New Information in Medicine
|
Jan 31, 2020 |
|
2.34 Red Light, Pola for DLBCL, Hem/Onc Question of the Week, & TAILORx with Dr. Ali Khaki
|
Jan 24, 2020 |
|
2.33 Olaparib and POLO & the Classical Fallacies of Cancer Screening with Dr. H Gilbert Welch
|
Jan 15, 2020 |
|
2.32 BONUS! Clinical Trials Part 1: Thinking Better About Cancer Medicine
|
Jan 10, 2020 |
|
2.31 Listener Questions, Responsibility of Reviewers, & Duration of Response with Dr. Bishal Gyawali
|
Jan 07, 2020 |
|
2.30 Questions from a Medical Student & Epidemiology with Dr. Ellie Murray
|
Jan 03, 2020 |
|
2.29 Time from Diagnosis to Treatment in AML and Real-World Data with Dr. Sherrie Aspinall
|
Dec 27, 2019 |
|
2.28 Trastuzumab in Later Lines of Therapy for HER2+ Breast Cancer, Kaplan-Meier Curves, & Patreon
|
Dec 20, 2019 |
|
2.27 BONUS! Use of Bone-Modifying Agents Among Medicare Beneficiaries with MM with Dr. Arjun Gupta
|
Dec 12, 2019 |
|
2.26 Questions of the Week: Hematology/Oncology, USMLE Step 2 CK, & a bonus Hematology/Oncology
|
Dec 09, 2019 |
|
2.25 Questions of the Week: Hematology/Oncology, the USMLE Step 2 CK, & One From a Med Student
|
Dec 02, 2019 |
|
2.24 Questions of the Week: the USMLE Step 2 CK, Hematology/Oncology, & One From a Med Student
|
Nov 26, 2019 |
|
2.23 Question of the Week & Ethics and Inefficiencies of Clinical Trials with Dr. Jonathan Kimmelman
|
Nov 20, 2019 |
|
2.22 Question of the Week & EMR, Talking to Patients, and Being a Doctor with Dr. Robert Hirschtick
|
Nov 15, 2019 |
|
2.21 Aiming for the Hard Targets & Harm From Screening and Overdiagnosis with Dr. H Gilbert Welch
|
Nov 08, 2019 |
|
2.20 "Courageous Skeptics", Lenalidomide, QOTW, and a Political Conversation with Dr. Andy Saultz
|
Nov 01, 2019 |
|
2.19 Remembering Dr. Bernard Fisher & Self-Diagnosis with Dr. Mark Lewis
|
Oct 25, 2019 |
|
2.18 Questions of the Week, Talking About Toxicity, ASCO Guidelines Authors' COI with Dr. Eitan Amir
|
Oct 18, 2019 |
|
2.17 Questions of the Week, BEACON, & Use of Subacuate Rehab with Dr. Jonathan Yeh
|
Oct 08, 2019 |
|
2.16 FLAURA & What Truly Matters in the Career of an Academic Physician with Dr. Vinay Prasad
|
Oct 02, 2019 |
|
2.15 Bonus! The Value of Progression-Free Survival as a Treatment Endpoint with Dr. Michael Raphael
|
Sep 26, 2019 |
|
2.14 Questions of the Week & Qualifications of a Fellowship Applicant with Dr. Jeremy Cetnar
|
Sep 24, 2019 |
|
2.13 BONUS! RCTs Supporting Approvals of Cancer Drugs by EMA with Dr. Huseyin Naci
|
Sep 20, 2019 |
|
2.12 Questions of the Week, Ethics of RCTs, & Transmission and Medical Overuse with Dr. Dan Morgan
|
Sep 17, 2019 |
|
2.11 Questions of the Week, When RCTs are Necessary, & AYA Oncology with Dr. Adam Duvall
|
Sep 12, 2019 |
|
2.10 Questions of the Week: the USMLE Step 2 CK, the MKSAP, & Hematology/Oncology
|
Sep 05, 2019 |
|
2.09 Questions of the Week & Informed Consent in Clinical Trials with Dr. Lynn Jansen
|
Aug 28, 2019 |
|
2.08 Questions of the Week: the MKSAP, the USMLE Step 2 CK, & From a Med Student
|
Aug 22, 2019 |
|
2.07 Translational Research & Physical Examination Pet Peeves with Dr. Adam Cifu
|
Aug 16, 2019 |
|
2.06 Heart Failure, Choosing a Specialty, & the Bayesian Approach with Dr. Frank Harrell
|
Aug 06, 2019 |
|
2.05 Reup! Cancer Screening 101 with Dr. Adam Obley
|
Jul 31, 2019 |
|
2.04 Reup! Tumor-Treating Fields for Glioblastoma with Dr. Michael Hayes
|
Jul 30, 2019 |
|
2.03 Dr. Charles Moertel and the Modern Oncologist & Cancer Screening 101 with Dr. Adam Obley
|
Jul 23, 2019 |
|
2.02 BONUS! Improving Access to Prescription Drugs through Policy Change with Dr. Stacie Dusetzina
|
Jul 17, 2019 |
|
2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter
|
Jul 12, 2019 |
|
1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma
|
Jul 05, 2019 |
|
1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina
|
Jun 27, 2019 |
|
1.66 Employing Medical Writers & Frequentist vs Bayesian Methods with Dr. Allen Pannell
|
Jun 20, 2019 |
|
1.65 BONUS! Focusing and Building Your Presence on Twitter
|
Jun 12, 2019 |
|
1.64 Effectiveness of Cancer Screening with Dr. Joaquín Chapa and POLO with Dr. Emerson Chen
|
Jun 06, 2019 |
|
1.63 POLO, TITAN, & from ASCO: FDA Approval, Surrogate Endpoints, and Patient Experience
|
Jun 04, 2019 |
|
1.62 Rates of Cancer Screening, BILCAP Outcry, Waterfall Plots and Response Rate, & Dr. Jeff Sharman
|
May 23, 2019 |
|
1.61 Postpublication Metrics of RCTs, PCP Appointment Time, Bortezomib, & Dr. Christopher Booth
|
May 15, 2019 |
|
1.60 I-PREDICT, Flawed Phase I Trials, & the Cost of Drugs with Dr. Daniel Hartung
|
May 09, 2019 |
|
1.59 BONUS! Should Evidence Come with an Expiration Date? with Palmer Greene
|
May 08, 2019 |
|
1.58 Magic Mouthwash with Dr. Arjun Gupta & Precision Oncology with Dr. Talal Hilal
|
May 07, 2019 |
|
1.57 BONUS! Control Arm Quality in RCTs Leading to Anticancer Drug FDA Approval with Dr. Talal Hilal
|
May 02, 2019 |
|
1.56 BONUS! Real World Data & the Search for Meaningful Cancer Care with Dr. Christopher Booth
|
May 01, 2019 |
|
1.55 Role of a Professional Society & More with Dr. Cliff Hudis of ASCO
|
Apr 29, 2019 |
|
1.54 Association of Patient Characteristics and Tumor Genomics with Clinical Outcomes & SABR-COMET
|
Apr 18, 2019 |
|
1.53 CALGB 50303, REMoDL-B, & REMS, Orphan Drug Act, and Role of the FDA with Dr. Ameet Sarpatwari
|
Apr 11, 2019 |
|
1.52 BILCAP & DOACs for Thromboprophylaxis in Patients with Cancer with Dr. Sven Olson
|
Apr 04, 2019 |
|
1.51 BONUS! Study Time Reduction Using Surrogate End Points with Dr. Emerson Chen
|
Apr 02, 2019 |
|
1.50 Replacing RCTs, Physicians on Twitter, Open-Access, & Orthopedics with Dr. Kathryn Schabel
|
Mar 29, 2019 |
|
1.49 Student Questions, Boeing 737 Max, Pancreatic Surveillance, Leukemia Drugs with Dr. Elihu Estey
|
Mar 22, 2019 |
|
1.48 Falsified Data in Meta-Analyses and the Expert Halo Effect with Dr. Stephanie Halvorson
|
Mar 13, 2019 |
|
1.47 BONUS! Medical Reversal: Class Lecture
|
Mar 11, 2019 |
|
1.46 BONUS! Personal Finances with Dr. Tom Beer
|
Mar 08, 2019 |
|
1.45 Real-World Data, Gottlieb, & Using the EHR for Meaningful Improvement with Dr. Deborah Cohen
|
Mar 06, 2019 |
|
1.44 BONUS! Screen Time and Children's Performance
|
Mar 01, 2019 |
|
1.43 Andexanet Alfa with Dr. Tom Deloughery & National Medicaid Policy with Dr. John McConnell
|
Feb 22, 2019 |
|
1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández
|
Feb 13, 2019 |
|
1.41 Geneva Oath and Financial Relationships Among Guideline Authors with Dr. Joshua Niforatos
|
Feb 09, 2019 |
|
1.40 The World of Hematology with Dr. Thomas Deloughery
|
Feb 06, 2019 |
|
1.39 Looking Back On a Tenure in Medicine with Dr. Alex Denes
|
Feb 02, 2019 |
|
1.38 Lartruvo, New Directions for Cancer Trials, Gene Expression Profiling, & Dr. Miriam Knoll
|
Jan 26, 2019 |
|
1.37 BONUS! Medical Reversal for a General Audience
|
Jan 18, 2019 |
|
1.36 Generic Price Competition & Military Surgical Advances with Dr. Martin Schreiber
|
Jan 15, 2019 |
|
1.35 BONUS! Conflict of Interest in Oncology
|
Jan 10, 2019 |
|
1.34 Endpoints in ECOG-ACRIN 2511, Update to KEYNOTE-024, & Mentorship with Dr. Joseph Shatzel
|
Jan 10, 2019 |
|
1.33 Guarantee-Time Bias & Trials, Philanthropy, and Cancer Research with Dr. Tom Beer
|
Jan 05, 2019 |
|
1.32.1 Radiation Oncology with Dr. Brian Kavanagh
|
Jan 04, 2019 |
|
1.32 Rating Metrics, Conflict of Interest in the News, & Radiation Oncology with Dr. Brian Kavanagh
|
Jan 03, 2019 |
|
1.31 Ketogenic Diet, COMET-1 and COMET-2, the Health Insurance Marketplace with Dr. Jane Zhu
|
Dec 27, 2018 |
|
1.30 BONUS! Clinical Trial Endpoints, Drug Approval, Incentives in Oncology
|
Dec 19, 2018 |
|
1.29 RCT of Parachutes and Frameworks for Internal Medicine with Dr. Andre Mansoor
|
Dec 18, 2018 |
|
1.28 Questionable FDA Drug Approvals and Building a Career with Dr. Chadi Nabhan
|
Dec 13, 2018 |
|
1.27 BONUS! Medical Reversal
|
Dec 06, 2018 |
|
1.26 Lesson From an ASH Abstract, Behind the Scenes of a Residency Program with Dr. Sima Desai
|
Dec 04, 2018 |
|
1.25 Welch's Legacy, Interpreting NGS, Uncertainty over Pregabalin, Beyond EBM with Dr. Sam Edwards
|
Nov 27, 2018 |
|
1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate
|
Nov 20, 2018 |
|
1.23 BONUS! Developing Technology with Fewer Reversals: Maybe We Need More Translation Failure
|
Nov 15, 2018 |
|
1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner
|
Nov 13, 2018 |
|
1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees
|
Nov 06, 2018 |
|
1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross
|
Oct 30, 2018 |
|
1.19 BONUS! Introduction to Cancer Drug Policy
|
Oct 26, 2018 |
|
1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan
|
Oct 23, 2018 |
|
1.17 BONUS! Interpretation of Cancer Clinical Trials
|
Oct 22, 2018 |
|
1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong
|
Oct 17, 2018 |
|
1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare
|
Oct 16, 2018 |
|
1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing
|
Oct 12, 2018 |
|
1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu
|
Oct 08, 2018 |
|
1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology
|
Oct 03, 2018 |
|
1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali
|
Oct 02, 2018 |
|
1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet
|
Sep 25, 2018 |
|
1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints
|
Sep 20, 2018 |
|
1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds
|
Sep 14, 2018 |
|
1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola
|
Sep 11, 2018 |
|
1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority
|
Sep 07, 2018 |
|
1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity
|
Sep 05, 2018 |
|
1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser
|
Aug 30, 2018 |
|
1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross
|
Aug 21, 2018 |
|
1.02: HemOnc Fellowship and Hype in Cancer Medicine with Dr. Jeremy Cetnar
|
Aug 16, 2018 |
|
1.01: Introduction and Dr. Adam Obley
|
Aug 14, 2018 |